What is the appropriate infertility and abnormal‑bleeding work‑up and management for a 34‑year‑old G0 woman with a 4‑year history of intermenstrual spotting, BMI 27, normal‑sized uterus with no adnexal masses on imaging, and LMP 5 weeks ago who desires pregnancy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 24, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Workup and Management for Infertility with Intermenstrual Spotting

This 34-year-old woman requires simultaneous evaluation of both her abnormal uterine bleeding and infertility, starting with transvaginal ultrasound (combined transabdominal and transvaginal with Doppler), followed by assessment of ovarian reserve, ovulatory function, tubal patency, and partner semen analysis.

Initial Imaging Evaluation

The first step is combined transabdominal and transvaginal ultrasound with Doppler, which is the most appropriate initial imaging study for abnormal uterine bleeding 1. This will evaluate for:

  • Endometrial polyps
  • Submucosal fibroids
  • Adenomyosis
  • Endometrial thickness and abnormalities
  • Ovarian morphology (including polycystic ovarian morphology)
  • Antral follicle count for ovarian reserve assessment 2

If the initial ultrasound is inconclusive or the uterus is incompletely visualized, sonohysterography should be performed if a polyp is suspected, or MRI pelvis without and with contrast if other pathology is suspected 1.

Infertility Workup Components

Given her age (34 years) and 7 years of attempting conception, she meets criteria for infertility evaluation. The essential components include 3:

Female Factor Assessment:

  • Ovarian reserve testing: TSH, day 3 FSH, AMH, and antral follicle count on ultrasound
  • Ovulatory function: Mid-luteal progesterone (day 21 of cycle) or ovulation predictor kits
  • Tubal patency evaluation: Hysterosalpingography (HSG) is indicated to assess fallopian tube patency 2, 3
  • Thyroid function: TSH to rule out thyroid dysfunction as cause of both bleeding and infertility 4

Male Factor Assessment:

Semen analysis should be obtained early in the workup, as male factor contributes to 40-50% of infertility cases 3. This is critical and should not be delayed.

Abnormal Bleeding Evaluation

For her 4-year history of intermenstrual spotting, additional considerations include:

  • Endometrial biopsy is NOT immediately indicated in this case, as she is under 35 years without risk factors for endometrial cancer and does not have recurrent anovulation 4
  • Pregnancy test (hCG) to exclude current pregnancy 5
  • Complete blood count to assess for anemia from chronic bleeding 5
  • Coagulation screening if heavy bleeding is present (von Willebrand disease screening) 4

Management Algorithm Based on Findings

If Structural Abnormalities Found (polyps, fibroids):

  • Hysteroscopic polypectomy or myomectomy before attempting conception, as these can interfere with implantation 2, 4

If Ovulatory Dysfunction Identified:

  • Address underlying cause (PCOS, thyroid dysfunction, hyperprolactinemia)
  • Ovulation induction with clomiphene citrate or letrozole for fertility
  • This simultaneously addresses both bleeding and infertility 4, 6

If Tubal Factor Identified:

  • Referral to reproductive endocrinology for consideration of tubal surgery vs. IVF 2

If No Structural Cause Found and Bleeding Persists:

Since she desires pregnancy, avoid hormonal contraceptives for bleeding management. Instead:

  • Tranexamic acid during bleeding episodes (does not affect fertility) 4, 5
  • NSAIDs during menses 4, 5

Critical Pitfalls to Avoid

  1. Do not delay male partner evaluation - obtain semen analysis concurrently with female workup 3
  2. Do not start hormonal contraceptives for bleeding control in someone actively trying to conceive
  3. Do not perform endometrial biopsy routinely in women under 35 without risk factors 4
  4. Do not skip tubal patency testing - 14% of infertility is due to tubal damage 2
  5. Expedite evaluation given age 34 - she is approaching the threshold where evaluation should occur after only 6 months of trying 3

Timing Considerations

Given her age (34 years), treatment should be initiated promptly after diagnosis rather than waiting additional months 3. If unexplained infertility is diagnosed (normal ovulation, tubal patency, normal semen analysis), she should be referred to reproductive endocrinology for consideration of intrauterine insemination or IVF, as 30% of infertile couples have unexplained infertility 3.

The intermenstrual spotting may resolve once pregnancy is achieved or underlying causes (anovulation, structural lesions) are treated. Prioritize fertility evaluation and treatment over bleeding management, using non-hormonal options for bleeding control as needed.

References

Guideline

acr appropriateness criteria® abnormal uterine bleeding.

Journal of the American College of Radiology, 2020

Guideline

acr appropriateness criteria® female infertility.

Journal of the American College of Radiology, 2020

Research

Clinical practice guidelines on menorrhagia: management of abnormal uterine bleeding before menopause.

European journal of obstetrics, gynecology, and reproductive biology, 2010

Research

Unmet needs in abnormal uterine bleeding due to ovulatory dysfunction.

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2024

Related Questions

In a 24-year-old woman with irregular intermenstrual bleeding and spotting, what is the appropriate diagnostic work-up and initial management?
What contraceptive is suitable for a 20-year-old with abnormal uterine bleeding (AUB)?
In a 41-year-old woman with a regular menstrual cycle, last menstrual period on [date], recurrent vaginal bleeding since [date], normal hemoglobin, heavy menstrual bleeding, endometrial thickness of 8.6 mm, and bilaterally normal ovaries, is a watch‑and‑wait approach appropriate?
A 50-year-old woman with a month of continuous menstrual‑type vaginal bleeding; what is the appropriate evaluation and management?
What evaluation and management should be recommended for a 51-year-old healthy woman with irregular menses and heavy menstrual bleeding over the past two months, requiring pad changes every 2 hours for five days?
In an 85‑year‑old man with cholangitis and elevated bilirubin, CT shows a markedly dilated common bile duct (up to 14 mm) but endoscopic ultrasound reveals no obstructive lesion; should ERCP with biliary cannulation, brush cytology, and stent placement be performed, and what type of stent is appropriate?
Is urate‑lowering therapy with allopurinol or febuxostat indicated in a patient with familial hyperuricemia who has never had gout?
What are the causes, diagnostic workup, and treatment for anemia in critically ill infants?
What are the recent cardiology updates for 2025–2026, including newly FDA‑approved agents and label expansions?
Can Morton's neuroma cause toe numbness?
What is the appropriate medical management for sciatica pain caused by a herniated disc?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.